Product category:
Chemical analysis equipment
News Release from: Procognia
Edited by the Laboratorytalk Editorial
Team on 16 November 2006
Offering 'breakthrough' protein array
platform
PerkinElmer and Procognia announced in December 2004 an agreement to deliver the only complete solution for high-throughput and high-resolution analysis of the glycosylation of proteins
Procognia's U-c fingerprint lectin array-based platform is being combined with PerkinElmer's advanced instrumentation, the Protein Array Workstation and the recently introduced ProScanArray HT, to offer the industry's first high-throughput, high-resolution glycoanalysis capability Certain scientific estimates indicate that more than 60% of critical biological functions involve glycosylated proteins
This article was originally published on Laboratorytalk on 23 Jan 2002 at 8.00am (UK)
Related stories
Functional proteins for cancer research
Sense Proteomic has announced that Expressarray p53, its first functional protein array product to aid in cancer research, is now available to researchers
First commercial array of functional proteins
Collection of functional potassium channel regulatory proteins, immobilised in microtitre plate format, is said to be the first functional protein array to be made commercially available
This new technology will drive significant advancements in the understanding of protein function and structure.
U-c fingerprint technology requires no sample purification or pretreatment, and allows the quantitative analysis of 20 samples in approximately three hours.
In addition, glycosylation analysis throughout the therapeutic protein discovery, development and manufacturing process will bring biopharmaceutical companies closer to satisfying the FDA's PAT (process analytical technology) initiative.
This technology is focused on reducing the time and cost of producing higher quality biopharmaceuticals.
"Procognia is a leader in proteomic technologies and together with PerkinElmer's extensive capabilities, we can now offer the industry's first complete high-throughput, high-resolution glycoanalysis platform for academic, biotech, and pharmaceutical customers," said Peter Coggins, president, PerkinElmer Life and Analytical Sciences.
"We believe we can accelerate adoption of Procognia's U-c fingerprint technology and firmly establish it as the gold standard in the monitoring and control of glycosylation of proteins by teaming with a global life sciences solutions provider like PerkinElmer," said Ron Long, CEO of Procognia .
• Procognia: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
